HOOKIPA Pharma Inc.
HOOKOTCHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $43.9M | $20.1M | $14.2M | $18.4M | $19.6M | $11.9M |
| Operating income | −$51.5M | −$97.7M | −$73.2M | −$81.7M | −$53.3M | −$51.1M |
| Net income | −$43.5M | −$81.6M | −$64.9M | −$75.7M | −$44.1M | −$43.0M |
| Total assets | $82.5M | $161.3M | $170.5M | $126.0M | $187.8M | $143.7M |
| Total liabilities | $31.3M | $71.5M | $67.9M | $36.5M | $31.7M | $25.8M |
| Equity | $51.2M | $89.9M | $102.5M | $89.6M | $156.1M | $117.9M |
| EPS (diluted) | $-3.47 | $-8.63 | $-9.91 | $-2.30 | $-1.69 | $-2.41 |
| Shares out. | 12.5M | 9.5M | 6.6M | 32.8M | 26.0M | 17.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −117.1%
- Net margin
- −99.0%
- Return on equity
- −84.9%
- Return on assets
- −52.7%
- Return on capital (ROCE)
- −88.9%
- Liabilities / assets
- 38.0%
- Debt / equity
- 0.61×
- Book value / share
- $4.08
- Revenue growth (YoY)
- 118.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -14.32distress
- Accruals / assets
- 40.6%high accruals
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Sofinnova Capital Vi FcprActivist (13D)Feb 14, 2025
- Ecor1 Capital, LlcPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 10,612 | 1.0 | -0.0% |
| Apr 30, 2026 | 10,613 | 1.0 | -3.8% |
| Apr 15, 2026 | 11,029 | 1.0 | -0.3% |
| Mar 31, 2026 | 11,064 | 1.0 | -7.3% |
| Mar 13, 2026 | 11,937 | 1.0 | -46.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteJul 29, 2025
- Delisting / listing-standard notice · Other material eventJul 18, 2025
- Entered a material agreement · Terminated a material agreement · Director / officer change · Other material eventMay 22, 2025
- Other material eventFeb 20, 2025
- Regulation FD disclosureJan 29, 2025
- Other material eventJan 10, 2025
- Other material eventJan 7, 2025
- Other material eventJan 2, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.